Long versus short acting drugs for attention deficit/hyperactivity disorder in children and adolescents

The AGREE (Appraisal of Guidelines for Research and Evaluation) instrument was used to evaluate the quality of the guidelines identified in the literature search.12 Domains considered included scope and purpose, stakeholder involvement, rigour of development, clarity and presentation, applicability, and editorial independence. [...] The complete guideline development methodology is found on the SIGN website.13 The overall aim of the guideline was to provide a framework for the evidence based assessment and management of ADHD/HKD from which multi-disciplinary and multi-agency approaches could be developed locally. [...] Australian Guidelines on ADHD (2009) In 2009 the Royal Australasian College of Physicians published the Australian Guidelines on ADHD.6 This is an extensive guideline including recommendations and a discussion of the supporting evidence for all aspects of the diagnosis and treatment of ADHD. [...] This guideline addressed social and economic considerations in the treatment of ADHD, including the economic burden of ADHD and the cost-effectiveness of treatment. [...] NICE (2009) Clinical Guideline on ADHD In 2009, NICE published a Clinical Practice Guideline on the Diagnosis and Management of ADHD in children, young people and adults.5 A technology appraisal on “methylphenidate, atomoxetine and dexamfetamine for the treatment of ADHD in children and adolescents” informed the recommendations on drug treatment.16 The clinical practice guideline is high quality a